AAAAAA
Results: 1-25/43
Authors:
MODELL M
WONKE B
ANIONWU E
KHAN M
TAI SS
LLOYD M
MODELL B
Citation: M. Modell et al., A MULTIDISCIPLINARY APPROACH FOR IMPROVING SERVICES IN PRIMARY-CARE -RANDOMIZED CONTROLLED TRIAL OF SCREENING FOR HEMOGLOBIN DISORDERS, BMJ. British medical journal, 317(7161), 1998, pp. 788-791
Authors:
WONKE B
WRIGHT C
HOFFBRAND AV
Citation: B. Wonke et al., COMBINED THERAPY WITH DEFERIPRONE AND DESFERRIOXAMINE, British Journal of Haematology, 103(2), 1998, pp. 361-364
Authors:
HANSLIP JI
PRESCOTT E
LALLOZ M
LAYTON M
WONKE B
Citation: Ji. Hanslip et al., THE ROLE OF THE SPL POLYMORPHISM IN THE DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH THALASSEMIA MAJOR, British Journal of Haematology, 101, 1998, pp. 21-21
Authors:
HANSLIP JI
PRESCOTT E
AGNEW JE
WONKE B
Citation: Ji. Hanslip et al., RESPONSE TO BIPHOSPHONATE THERAPY FOR OSTEOPOROSIS IN THALASSEMIA MAJOR, British Journal of Haematology, 101, 1998, pp. 124-124
Authors:
HOFFBRAND AV
ALREFAIE F
DAVIS B
SIRITANAKATKUL N
JACKSON BFA
COCHRANE J
PRESCOTT E
WONKE B
Citation: Av. Hoffbrand et al., LONG-TERM TRIAL OF DEFERIPRONE IN 51 TRANSFUSION-DEPENDENT IRON-OVERLOADED PATIENTS, Blood, 91(1), 1998, pp. 295-300
Authors:
HOFFBRAND AV
WONKE B
Citation: Av. Hoffbrand et B. Wonke, IRON CHELATION-THERAPY, Journal of internal medicine, 242, 1997, pp. 37-41
Authors:
JENSEN CE
TUCK SM
OLD J
MORRIS RW
YARDUMIAN A
DESANCTIS V
HOFFBRAND AV
WONKE B
Citation: Ce. Jensen et al., INCIDENCE OF ENDOCRINE COMPLICATIONS AND CLINICAL-DISEASE SEVERITY RELATED TO GENOTYPE ANALYSIS AND IRON OVERLOAD IN PATIENTS WITH BETA-THALASSEMIA, European journal of haematology, 59(2), 1997, pp. 76-81
Authors:
RATIP S
PETROU M
OLD JM
WONKE B
PORTER JB
MONDELL B
Citation: S. Ratip et al., RELATIONSHIP BETWEEN THE SEVERITY OF BETA-THALASSEMIA SYNDROMES AND THE NUMBER OF ALLEVIATING MUTATIONS, European journal of haematology, 58(1), 1997, pp. 14-21
Authors:
TELFER PT
GARSON JA
WHITBY K
GRANT PR
YARDUMIAN A
HOFFBRAND AV
WONKE B
Citation: Pt. Telfer et al., COMBINATION THERAPY WITH INTERFERON-ALPHA AND RIBAVIRIN FOR CHRONIC HEPATITIS-C VIRUS-INFECTION IN THALASSEMIC PATIENTS, British Journal of Haematology, 98(4), 1997, pp. 850-855
Authors:
JENSEN CE
ABDELGADIR A
COX C
TUCK SM
WONKE B
Citation: Ce. Jensen et al., SPERM CONCENTRATIONS AND QUALITY IN BETA-THALASSEMIA MAJOR, International journal of andrology, 19(6), 1996, pp. 362-364
Authors:
ARAUJO A
KOSARYAN M
MACDOWELL A
WICKENS D
PURI S
WONKE B
HOFFBRAND AV
Citation: A. Araujo et al., A NOVEL DELIVERY SYSTEM FOR CONTINUOUS DESFERRIOXAMINE INFUSION IN TRANSFUSIONAL IRON OVERLOAD, British Journal of Haematology, 93(4), 1996, pp. 835-837
Authors:
REES DC
DULEY J
SIMMONDS HA
WONKE B
THEIN SL
CLEGG JB
WEATHERALL DJ
Citation: Dc. Rees et al., INTERACTION OF HEMOGLOBIN-E AND PYRIMIDINE 5'-NUCLEOTIDASE DEFICIENCY, Blood, 88(7), 1996, pp. 2761-2767
Authors:
TELFER PT
WHITBY K
GRANT P
GARSON JA
HOFFBRAND AV
WONKE B
Citation: Pt. Telfer et al., COMBINATION THERAPY WITH INTERFERON-ALPHA AND RIBAVIRIN FOR HEPATITIS-C VIRUS (HCV) INFECTION IN MULTIPLY TRANSFUSED THALASSEMIC PATIENTS, Blood, 88(10), 1996, pp. 2096-2096
Authors:
HOFFBRAND AV
WONKE B
ALREFAIE F
SIRITANARATKUL N
DAVIS B
JACKSON BFA
Citation: Av. Hoffbrand et al., OVER 3 YEAR FOLLOW-UP OF 56 TRANSFUSION DEPENDENT PATIENTS RECEIVING ORAL IRON CHELATION, Blood, 88(10), 1996, pp. 2592-2592
Authors:
HO PJ
ROCHETTE J
FISHER CA
WONKE B
JARVIS MK
YARDUMIAN A
THEIN SL
Citation: Pj. Ho et al., MODERATE REDUCTION OF BETA-GLOBIN GENE TRANSCRIPT BY A NOVEL MUTATIONIN THE 5'-UNTRANSLATED REGION - A STUDY OF ITS INTERACTION WITH OTHERGENOTYPES IN 2 FAMILIES, Blood, 87(3), 1996, pp. 1170-1178
Authors:
JENSEN CE
TUCK SM
WONKE B
Citation: Ce. Jensen et al., FERTILITY IN BETA-THALASSEMIA MAJOR - A REPORT OF 16 PREGNANCIES, PRECONCEPTUAL EVALUATION AND A REVIEW OF THE LITERATURE, British journal of obstetrics and gynaecology, 102(8), 1995, pp. 625-629
Authors:
HOFFBRAND AV
WONKE B
Citation: Av. Hoffbrand et B. Wonke, DEFERIPRONE IN IRON OVERLOAD, The New England journal of medicine, 333(9), 1995, pp. 598-599
Authors:
ALREFAIE FN
DESILVA CE
WONKE B
HOFFBRAND AV
Citation: Fn. Alrefaie et al., CHANGES IN TRANSFERRIN SATURATION AFTER TREATMENT WITH THE ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH IRON OVERLOAD, Journal of Clinical Pathology, 48(2), 1995, pp. 110-114
Authors:
ALREFAIE FN
HERSHKO C
HOFFBRAND AV
KOSARYAN M
OLIVIERI NF
TONDURY P
WONKE B
Citation: Fn. Alrefaie et al., RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS, British Journal of Haematology, 91(1), 1995, pp. 224-229
Authors:
ALREFAIE FN
SHEPPARD LN
NORTEY P
WONKE B
HOFFBRAND AV
Citation: Fn. Alrefaie et al., PHARMACOKINETICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L(1)) IN PATIENTS WITH IRON OVERLOAD, British Journal of Haematology, 89(2), 1995, pp. 403-408
Authors:
HO PJ
ROCHETTE J
FISHER CA
WONKE B
JARVIS M
YARDUMIAN A
THEIN SL
Citation: Pj. Ho et al., MODERATE REDUCTION OFF GLOBIN GENE TRANSCRIPT BY A NOVEL MUTATION IN THE 5'-UNTRANSLATED REGION, Blood, 86(10), 1995, pp. 12-12
Authors:
ROBERTS IAG
DOKAL I
WONKE B
BASU S
DARBYSHIRE P
Citation: Iag. Roberts et al., BMT FOR CHILDREN WITH BETA-THALASSEMIA MAJOR, Blood, 86(10), 1995, pp. 1918-1918
Authors:
HILETI D
SHALEV O
TELFER PT
NORTEY P
WONKE B
HEBBEL RP
HOFFBRAND AV
Citation: D. Hileti et al., L1 (DEFERIPRONE) ACCUMULATES WITHIN THALASSEMIC BUT NOT NORMAL OR SICKLE RED-BLOOD-CELLS, Blood, 86(10), 1995, pp. 1921-1921
Authors:
TELFER PT
WHITBY K
GARSON JA
HOFFBRAND AV
WONKE B
Citation: Pt. Telfer et al., ALPHA-INTERFERON ALONE AND IN COMBINATION WITH RIBAVIRIN FOR HEPATITIS-C VIRUS (HCV) INFECTION IN MULTIPLY TRANSFUSED THALASSEMIC PATIENTS, Blood, 86(10), 1995, pp. 1924-1924
Authors:
JENSEN CE
TUCK SM
HOFFBRAND AV
YARDUMIAN A
KONERU S
WONKE B
Citation: Ce. Jensen et al., OSTEOPOROSIS IN MULTIPLY TRANSFUSED THALASSEMIC PATIENTS, Blood, 86(10), 1995, pp. 2585-2585